Email this article Adjuvant hormone therapy in postmenopausal patients with locally advanced breast cancer: hope and reality
- Authors: Borisov V.I.1
-
Affiliations:
- Clinical Oncology Dispensary One, Moscow
- Issue: No 2 (2011)
- Pages: 30-36
- Section: MAMMOLOGY. LECTURE
- Published: 25.05.2011
- URL: https://ojrs.abvpress.ru/ojrs/article/view/158
- DOI: https://doi.org/10.17650/1994-4098-2011-0-2-30-36
- ID: 158
Cite item
Full Text
Abstract
The clinical efficiency of adjuvant hormone therapy has been considered in patients with operable breast cancer in international ran- domized mulricenter studies. The use of aromatase inhibitors versus tamoxifen is shown to considerably improve relapse-free survival and to reduce the risk of distant metastases and contralateral breast cancer.
Keywords
About the authors
V. I. Borisov
Clinical Oncology Dispensary One, Moscow
Author for correspondence.
Email: okd1@mosgorzdrav.ru
Russian Federation
References
Supplementary files
